Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Sales | 4,778,000 | 4,819,000 | 4,626,000 | 5,076,000 | 5,372,000 |
| Cost of Goods | 1,467,000 | 1,500,000 | 1,357,000 | 1,525,000 | 1,929,000 |
| Gross Profit | 3,311,000 | 3,319,000 | 3,269,000 | 3,551,000 | 3,443,000 |
| Operating Expenses | 2,156,000 | 2,242,000 | 2,163,000 | 2,382,000 | 2,127,000 |
| Operating Income | 1,155,000 | 1,077,000 | 1,106,000 | 1,169,000 | 1,316,000 |
| Other Income | -9,000 | -308,000 | 358,000 | -246,000 | 45,000 |
| Pre-tax Income | 1,146,000 | 769,000 | 1,464,000 | 923,000 | 1,361,000 |
| Income Tax | 239,000 | 118,000 | 396,000 | 292,000 | 345,000 |
| Net Income Continuous | 755,000 | 523,000 | 961,000 | 506,000 | 906,000 |
| Net Income Discontinuous | 3,000 | 4,000 | 3,000 | N/A | N/A |
| Net Income | $758,000 | $527,000 | $964,000 | $506,000 | $906,000 |
| EPS Basic Total Ops | 0.39 | 0.27 | 0.50 | 0.26 | 0.47 |
| EPS Basic Continuous Ops | 0.39 | 0.27 | 0.50 | 0.26 | 0.47 |
| EPS Diluted Total Ops | 0.38 | 0.27 | 0.49 | 0.26 | 0.47 |
| EPS Diluted Continuous Ops | 0.38 | 0.27 | 0.49 | 0.26 | 0.47 |
| EBITDA(a) | $1,393,000 | $1,289,000 | $1,310,000 | $1,404,000 | $1,507,000 |